EUVIMEDOpdag EUVIMED
Open access

Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma

Giorgia Nasi iD, Leonie C Schöftner iD, Lara Ronacher, Amalia Sophianidis iD, Julia Feiser iD, Teodora Aleksandrova iD, Oliver Nussbaumer iD, Andrew Hutton, Roland Zauner iD, Johanna Moser-Waxenecker iD, Suraj R Varkhande iD, Anshu Sharma iD and 5 more

Science Advances · 2026-06-26 · 12 (26)

DOI: 10.1126/sciadv.aec7215 ↗

At a glance

Journal article in Science Advances, published on 2026-06-26. Written by Giorgia Nasi and 16 co-authors. Institution: Department of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria. Major MEDLINE topics: Carcinoma, Squamous Cell, Cutaneous Squamous Cell Carcinoma, Immunotherapy, Intraepithelial Lymphocytes. 58 references. The full text is freely available in PubMed Central. Funded by: FWF, GammaDelta Therapeutics Ltd and Takeda Pharmaceutical, Center for tumor biology and immunology (CTBI), University of Salzburg.

AbstractSubjectsBibliografiske oplysningerCiteRelated studies

Abstract (original language)

Gamma delta (γδ) T cells are critical for tissue immune surveillance and their presence in tumors correlates with a favorable prognosis, highlighting their therapeutic potential. Although γδ T cells are abundant in the skin, their therapeutic value in skin cancer has remained largely unexplored due to challenges in isolating sufficient numbers of γδ T cells from human tissues and a lack of suitable preclinical models for skin cancer. Here, we are using innovative methods to expand human cutaneous γδ T cells ex vivo, enabling us to investigate their therapeutic potential in a human cutaneous squamous cell carcinoma (cSCC) mouse model. In this model, γδ T cells were specifically recruited to and maintained in the cSCC xenograft. These tumor-infiltrating cells exhibited an activated, cytotoxic phenotype and demonstrated effective antitumor activity in vivo. Collectively, our findings provide preclinical evidence supporting human skin–resident γδ T cells as a promising immunotherapeutic approach for treating skin cancers such as cSCC.

Subjects

MeSH terms (MEDLINE)

Carcinoma, Squamous CellCutaneous Squamous Cell CarcinomaImmunotherapyIntraepithelial LymphocytesReceptors, Antigen, T-Cell, gamma-deltaSkinT-LymphocytesAnimalsHumansMiceCell Line, TumorDisease Models, AnimalLymphocytes, Tumor-InfiltratingXenograft Model Antitumor Assays

Substances

Receptors, Antigen, T-Cell, gamma-delta

Authors and institutions

  • Department of Biosciences and Medical Biology, University of Salzburg, Salzburg, Austria.
  • Institute of Medical Systems Biology, Johannes Kepler University Linz, Linz, Austria.
  • GammaDelta Therapeutics Ltd, London, UK.
  • Takeda Pharmaceuticals, Oncology Drug Discovery Unit, Cambridge, MA, USA.
  • EB House Austria, Research Program for Molecular Therapy of Genodermatoses, Department of Dermatology and Allergology, University Hospital of the Paracelsus Medical University, Salzburg, Austria.
  • Department of Dermatology and Venereology, Kepler University Hospital Linz, Linz, Austria.

ORCID profiles: Giorgia Nasi, Leonie C Schöftner, Amalia Sophianidis, Julia Feiser, Teodora Aleksandrova, Oliver Nussbaumer, Roland Zauner, Johanna Moser-Waxenecker, Suraj R Varkhande, Anshu Sharma, Teresa Burner, Christina Guttmann-Gruber, Iris K Gratz

Funding

  • FWF
  • GammaDelta Therapeutics Ltd and Takeda Pharmaceutical
  • Center for tumor biology and immunology (CTBI), University of Salzburg

Cite

APA

Nasi, G., Schöftner, L. C., Ronacher, L., Sophianidis, A., Feiser, J., Aleksandrova, T., Nussbaumer, O., Hutton, A., Zauner, R., Moser-Waxenecker, J., Varkhande, S. R., Sharma, A., Ettinger, M., Burner, T., Laimer, M., Guttmann-Gruber, C., & Gratz, I. K. (2026). Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma. Science Advances, 12(26). https://doi.org/10.1126/sciadv.aec7215

Vancouver

Nasi G, Schöftner LC, Ronacher L, Sophianidis A, Feiser J, Aleksandrova T, et al. Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma. Science Advances. 2026;12(26). doi:10.1126/sciadv.aec7215

BibTeX
@article{Nasi2026,
  author = {Nasi, Giorgia and Schöftner, Leonie C and Ronacher, Lara and Sophianidis, Amalia and Feiser, Julia and Aleksandrova, Teodora and Nussbaumer, Oliver and Hutton, Andrew and Zauner, Roland and Moser-Waxenecker, Johanna and Varkhande, Suraj R and Sharma, Anshu and Ettinger, Monika and Burner, Teresa and Laimer, Martin and Guttmann-Gruber, Christina and Gratz, Iris K},
  title = {Harnessing skin-resident γδ T cells for immunotherapy in cutaneous squamous cell carcinoma},
  journal = {Science Advances},
  year = {2026},
  volume = {12},
  number = {26},
  doi = {10.1126/sciadv.aec7215}
}
Start for free →